Pear Therapeutics Announces Formulary Availability for its Three FDA Authorized Prescription Digital Therapeutics at OptumRx

S-Alpha Therapeutics, Inc., Digital Therapeutics Start-up Raises $8.7 Million in Series A Funding

Report: Digital health tools maturing as research, funding grows

Digital Therapeutics for Substance Use Disorders: From Research to Practice

Study finds Pear’s reSET-O could lower costs of treating opioid use disorder

From Theory to Real-World Practice: Clinical Integration of Digital Therapeutics

Digital MSK therapy tool Kaia gives equally reliable exercise recommendations as physiotherapists, study finds

Pear Therapeutics Announces Publication of Healthcare Resource Utilization Data Analysis Showing Real-World Cost Impact of reSET-O® in Treating Opioid Use Disorder

MedRhythms hits a high note with $25M for music-based stroke, Parkinson’s, MS treatment

Amwell Enhances Virtual Care Platform with Two Acquisitions: SilverCloud Health and Conversa Health

Copyright © 2025 Digital Therapeutics Alliance™